ImageneBio (IMA) FCF Margin Growth (1y) (2021 - 2024)
ImageneBio (IMA) FCF Margin Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 811.00 |
| 10 | ImageneBio | 47.41 Mn | -87.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 205,785.00 |
| Dec 31, 2023 | -302,250.00 |
| Sep 30, 2023 | -141,453.00 |
| Jun 30, 2023 | 442,477.00 |
| Mar 31, 2023 | 21,038.00 |
| Dec 31, 2022 | -25,934.00 |
| Sep 30, 2022 | 21,218.00 |
| Jun 30, 2022 | -488,178.00 |
| Mar 31, 2022 | -18,236.00 |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | -21,361.00 |
| Jun 30, 2021 | -19,740.00 |
| Mar 31, 2021 | -9,365.00 |